China National Accord Medicines Corp Ltd - Asset Resilience Ratio

Latest as of March 2024: -1.21%

China National Accord Medicines Corp Ltd (200028) has an Asset Resilience Ratio of -1.21% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check China National Accord Medicines Corp Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

HK$-621.65 Million
≈ $-79.36 Million USD Cash + Short-term Investments

Total Assets

HK$51.52 Billion
≈ $6.58 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1992–2023)

This chart shows how China National Accord Medicines Corp Ltd's Asset Resilience Ratio has changed over time. See China National Accord Medicines Corp Ltd (200028) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down China National Accord Medicines Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of China National Accord Medicines Corp Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents HK$0.00 0%
Short-term Investments HK$-621.65 Million -1.21%
Total Liquid Assets HK$-621.65 Million -1.21%

Asset Resilience Insights

  • Limited Liquidity: China National Accord Medicines Corp Ltd maintains only -1.21% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

China National Accord Medicines Corp Ltd Industry Peers by Asset Resilience Ratio

Compare China National Accord Medicines Corp Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
China National Medicines Corp Ltd
SHG:600511
Medical Distribution 0.04%
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.21%

Annual Asset Resilience Ratio for China National Accord Medicines Corp Ltd (1992–2023)

The table below shows the annual Asset Resilience Ratio data for China National Accord Medicines Corp Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -1.34% HK$-639.06 Million
≈ $-81.58 Million
HK$47.57 Billion
≈ $6.07 Billion
-1.34pp
2022-12-31 0.00% HK$2.00
≈ $0.26
HK$42.62 Billion
≈ $5.44 Billion
+1.75pp
2021-12-31 -1.75% HK$-747.96 Million
≈ $-95.48 Million
HK$42.78 Billion
≈ $5.46 Billion
-0.27pp
2020-12-31 -1.48% HK$-585.15 Million
≈ $-74.70 Million
HK$39.59 Billion
≈ $5.05 Billion
+0.03pp
2019-12-31 -1.51% HK$-505.36 Million
≈ $-64.51 Million
HK$33.52 Billion
≈ $4.28 Billion
+0.07pp
2018-12-31 -1.58% HK$-456.22 Million
≈ $-58.24 Million
HK$28.93 Billion
≈ $3.69 Billion
+0.24pp
2017-12-31 -1.82% HK$-405.93 Million
≈ $-51.82 Million
HK$22.34 Billion
≈ $2.85 Billion
-0.15pp
2016-12-31 -1.67% HK$-355.09 Million
≈ $-45.33 Million
HK$21.31 Billion
≈ $2.72 Billion
-0.26pp
2015-12-31 -1.40% HK$-185.57 Million
≈ $-23.69 Million
HK$13.22 Billion
≈ $1.69 Billion
-0.52pp
2014-12-31 -0.88% HK$-112.99 Million
≈ $-14.42 Million
HK$12.83 Billion
≈ $1.64 Billion
+0.14pp
2013-12-31 -1.02% HK$-113.26 Million
≈ $-14.46 Million
HK$11.06 Billion
≈ $1.41 Billion
+0.14pp
2012-12-31 -1.16% HK$-108.06 Million
≈ $-13.79 Million
HK$9.30 Billion
≈ $1.19 Billion
+0.22pp
2011-12-31 -1.39% HK$-106.27 Million
≈ $-13.57 Million
HK$7.67 Billion
≈ $978.56 Million
+0.31pp
2010-12-31 -1.70% HK$-107.10 Million
≈ $-13.67 Million
HK$6.31 Billion
≈ $805.09 Million
-0.46pp
2009-12-31 -1.24% HK$-64.69 Million
≈ $-8.26 Million
HK$5.23 Billion
≈ $668.08 Million
-0.17pp
2008-12-31 -1.07% HK$-39.26 Million
≈ $-5.01 Million
HK$3.68 Billion
≈ $470.27 Million
+0.65pp
2007-12-31 -1.71% HK$-49.72 Million
≈ $-6.35 Million
HK$2.91 Billion
≈ $370.97 Million
-2.06pp
2006-12-31 0.35% HK$9.42 Million
≈ $1.20 Million
HK$2.68 Billion
≈ $342.02 Million
+0.35pp
2003-12-31 0.00% HK$4.08K
≈ $520.83
HK$1.01 Billion
≈ $128.72 Million
+0.00pp
2002-12-31 0.00% HK$4.08K
≈ $520.83
HK$1.05 Billion
≈ $134.37 Million
0.00pp
2001-12-31 0.00% HK$4.68K
≈ $597.42
HK$1.12 Billion
≈ $142.74 Million
-6.38pp
2000-12-31 6.38% HK$31.30 Million
≈ $4.00 Million
HK$490.89 Million
≈ $62.66 Million
+6.38pp
1997-12-31 0.00% HK$2.00K
≈ $255.31
HK$495.82 Million
≈ $63.29 Million
-0.02pp
1996-12-31 0.02% HK$89.01K
≈ $11.36K
HK$446.60 Million
≈ $57.01 Million
0.00pp
1995-12-31 0.02% HK$89.01K
≈ $11.36K
HK$380.21 Million
≈ $48.53 Million
+0.00pp
1994-12-31 0.02% HK$88.51K
≈ $11.30K
HK$379.76 Million
≈ $48.48 Million
-2.53pp
1993-12-31 2.55% HK$9.80 Million
≈ $1.25 Million
HK$384.07 Million
≈ $49.03 Million
+2.50pp
1992-12-31 0.05% HK$97.26K
≈ $12.42K
HK$188.93 Million
≈ $24.12 Million
--
pp = percentage points

About China National Accord Medicines Corp Ltd

SHE:200028 China Medical Distribution
Market Cap
$125.06 Million
HK$979.65 Million HKD
Market Cap Rank
#18386 Global
#4670 in China
Share Price
HK$13.73
Change (1 day)
+0.59%
52-Week Range
HK$12.21 - HK$14.07
All Time High
HK$1125.97
About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more